Abstract
Apoptosis is a complex process involving a large array of genes and mutation of any of these genes may lead to malignancy formation. Tumor cells may actively evade the immune surveillance by actively inducing the apoptosis of effector lymphocytes, facilitating mass formation and metastasis. Apart from traditional therapies inducing tumor cell apoptosis, new strategies employing death receptor ligands and making use of tumor counterattack are also being developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaron C. Spalding, Robert M. Jotte, Robert I. Scheinman, Mark W. Geraci, Penny Clarke, Kenneth L. Tyler and Gary L. Johnson. (2002). TRAIL and inhibitors of apoptosis are opposing determinants for NF-kB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene. 21, 260 - 271.
Abigail Hunt and Gerard Evan. (2001). Apoptosis: Till Death Us Do Part, Science. 293, 1784 - 5.
Alexandre Nesterov, Yuri Ivashchenko, and Andrew S. Kraft (2002). Tumor necrosis factor-related apoptosisinducing ligand ( TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 21, 1135-1140.
Antonsson, B., and Martinou, J.C. (2000). The Bc1-2 protein family. Exp Cell Res. 256, 50 - 57.
Asher, G., Lotem, J., Cohen, B., and Shaul, Y. (2000). Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA. 98, 1188 - 1193.
Beutler, B. and Cerami, A. (1986). Cachetin and tumor necrosis factor as two sides of the same biological coin. Nature. 320, 584 - 588.
Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Celi. 85, 803 - 15.
Borner, C., and Monney, L. (1999). Apoptosis without cas-pases: an inefficient molecular guillotine? Cell Death Diff. 6, 497 - 507.
Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., and Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72, 3666-3670.
Chautan, M., Chazal, G., Cecconi, F., Gruss, P., and Golstein, P. (1999). Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol. 9, 967 - 970.
Cryns, V., and Yuan, J. (1998). Proteases to die for. Genes Dev. 12, 1551 - 70.
Daniel, P. (2000). Dissecting the pathways to death. Leukemia. 14, 2035 - 2044.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391, 43 - 50.
Eskes, R. Desagher, S. Antonsson, B. and Martinou, J. (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial mebrane. Mol. Cell. Biol. 20, 929 - 935.
Fan Xiaoqiang, and Yajun Guo. (2001). Apoptosis in oncology, Cell Research. 11, 1 - 7.
Fraker, D.L. and Alexander, H.R. (1994). Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma., Important adv. Oncol. 179 - 192.
Frederik H. Igney, Christian K. Behrens and Peter H. Krammer. (2000). Tumor counterattack-concept and reality. Eur. J. Immunol. 30, 725-731.
Gao, G., and Dou, P. (2000). N-terminal cleavage of bax by cal-pain generates a potent proapoptotic 18-kDa fragment that promotes Bcl-2-independent cyto-chrome c release and apoptotic cell death. J Cell Biochem. 80, 53 - 72.
Gen Sheng Wu and Zhenhua Ding. (2002). Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene. 21, 1 - 8.
Gordon J. Freeman, Arlene H. Sharpe and Vijay K. Kuchroo. (2002). Protect the killer: CTLs need defences against the tumor. Nat. Med. 8, 787 - 789.
Guo, B., Godzik, A., and Reed, J.C. (2001). Bel-G, a novel pro-apoptotic member of the Bc1-2 family. J Biol Chem. 276, 2780 - 2785.
Guoqing Chen and David V. Goeddel (2002). TNFRI signalling: a beautiful pathway, Science, 296, 1634 - 1635.
HaidongDong, Scoot E. Strome, Diva R. Salomao, Hideto Tamura, Fumiya Hirano, Dallas B. Flies, Patrick C. Roche, Jun Lu, Gefeng Zhu, Koji Tamada, Vanda A. Lennon, Esteban Celis, and Lieping Chen. (2002). Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion, Nature Medicine. 8, 793 - 800.
Heidi Leblance, David Lawrence, Eugene Varfolomeev, Klara Totpal, John Morlan, Peter Schow, Sharon Fong, Ralph Schwall, Dominick Sinicropi and Avi Ashkenzi. (2002). Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med. 8, 274 - 281.
Hermeking, H., and Eick, D. (1994). Mediation of c-Myc induced apoptosis by p53. Science. 265, 2091-2093. Hiroshi Arai, David Gordon, Elizabeth G. Nabel, and Gary J. Nabel. (1997). G.ne transfer of Fas ligand induces tumor regression in vivo, Proc. Natl. Acad. Sci. USA. 94, 13862 - 13867.
Howard Y. Chang and Xiaolu Yang (2000). Proteases for Cell Suicide: Functions and Regulation of Caspases. Micro Mol Biol Rev. 64, 821 - 846.
Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 81, 495 - 504.
Jo, M., Kim, T.H., Seol, D.W., Esplen, J.E., Dorko, K., Billiar, T.R., and Strom, S.C. (2000). Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat. Med. 6, 564-567.
Joe O’Connell, Michael W. Bennett, Gerald C., O’Sullivan, J. Kevin Collins and Fergus Shanahan. (1999). Fas counterattack-the best form of tumor defense ? Nat. Med. 5, 267 - 268.
Kataoka, T., Budd, R.C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., and Tschopp, J. (2000). The caspase inhibitor FLIP promotes activation of NF-KB and Erk signaling pathways. Curr. Biol, 10, 640 - 648.
Ke, N., Godzik, A., and Reed, J.C. (2001). Bel-B, a novel Bel-2 family member that differentially binds and regu-lates Bax and Bak. J Biol Chem. 276, 12481 - 12484.
Keane, M.M., Ettenberg, S.A., Nau, M.M., Russell, E.K., and Lipkowitz, S. (1999). Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res. 59, 734 - 41.
Kelly, M.M., Hoel, B.D., and Voelkel Johnson C. (2002). Doxorubicin Pretreatment Sensitizes Prostate Cancer Cell Lines to TRAIL Induced Apoptosis Which Correlates with the Loss of c-FLIP Expression. Cancer Biol. Ther. 1, 520 - 7.
Kitanaka, C., and Kuchino, Y. (1999). Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6, 508 - 515.
Krammer, P.H. (2000). CD95’s deadly mission in the immune system. Nature. 407, 789 - 795.
Li, X.K., Okuyama, T., Tamura, A., Enosawa, S., Kaneda, Y., Takahara, S., Funashima, N., Yamada, M., Amemiya, H., and Suzuki, S. (1998). Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation. 66, 1416 - 1423.
Liu, T.J., el-Naggar, A.K., McDonnell, T.J., Steck, K.D., Wang, M., Taylor, D.L., and Clayman, G.L. (1995). Apoptosis induction mediated by wild type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55, 3117 - 22.
Miller, T.M., Moulder, K.L., Knudson, C.M., Creedon, D.J., Deshmukh, M., Korsmeyer, S.J., and Johnson, E.M. Jr. (1997). Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspaseindependent pathway to cell death. J Cell Biol. 139, 205 - 217.
Xiang, J., Chao, D.T., and Korsmeyer, S.J. (1996). Bax-induced cell death may not require interleukin 1-convert-ing enzyme-like proteases. Proc Natl Acad Sci USA. 93, 14559 - 14563.
Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S., and Dixit, V.M. (1998). An induced proximity model for caspase-8 activation. J Biol Chem. 273, 2926 - 30.
Nicholas P. Restifo. (2000). Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape. Nat. Med. 6, 493 - 5.
Norbury, C., and Hickson, I. (2001). Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol. 41, 367 - 401.
O’Conell, J., Bennett. M.W., O’Sullivan G.C., Collin. J.K., and Shanahan F. (1999). The Fas counterattack: cancer as a site of immune privilege. Immunol. Today. 20, 46 - 52.
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. (2000). Noxa, a BH3-only member of the Bd-2 family and candidate mediator of p53-induced apoptosis. Science. 288, 1053 - 1058.
Porwit MacDonald, A., Ivory, K., Wilkinson, S., Wheatley, K., Wong, L., and Janossy, G. (1995). Bc1-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia. 9, 1191 - 8.
Reddy, R.K., Jun, L., and Lee, A.S. (1999). The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca21-binding and antiapoptotic properties is a novel proteolytic target of calpain during etopo-side induced apoptosis. J Biol Chem. 274, 28476 - 28483.
Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A., and Ashkenazi, A. (1996). Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family. J. Biol. Chem, 271, 12687 - 12690.
Rudel, T., and Bokoch, G.M. (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276, 1571 - 4.
Salvesen, G.S., and Dixit, V.M. (1999). Caspase activation: the induced proximity model. Proc. Natl. Acad. Sci. USA. 96, 10964-10967.
Scaffidi, C. et al. (1999). Differential modulation of apoptosis sensitivity in CD95 type 1 and type 2 cells. J. Biol. Chem. 274, 22532 - 22538.
Schendel, S.L., Azimov, R., Pawlowski, K., Godzik, A., Kagan, B., and Reed, J.C. (1999). Ion channel activity of the BH3 only Bel-2 family member Bid. J Biol Chem. 274, 21932 - 21936.
Sharad Kumar and David L. Vaux. (2002). A Cinderella Caspase Takes Center Stage. Science. 297, 1290 - 1.
Shkenazi, A., and Dixit, V. M. (1998). Death receptors: signaling and modulation. Science. 281, 1305-1308. Simone Fulda and Klaus-Michael Debatin. (2002). IFN g sensitizes for apoptosis by upregulating caspase-8 expression through the Statl pathway Oncogene. 21, 2295 - 2308.
Schulze Osthoff, K., Krammer, P.H., and Droege, W. (1994). Divergent signaling via APO-1/Fas and the TNF re-ceptor, two homologous molecules involved in physiological cell death. EMBO J. 13, 4587 - 4596.
Simone Fulda, Wolfgang Wick, Michael Weller and Klaus. Michael Debatin. (2002). Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nat. Med. 8, 808 - 815.
Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E.S. (1998). Autoactivation of procaspase-9 by Apaf-l-mediated oligomerization. Mol Cell. 1, 949 - 57.
Stoka, V., Turk, B., Schendel, S.L., et al. (2001). Lysosomal protease pathways to apoptosis. J Biol Chem. 276, 3149 - 3157.
Tang, D., Lahti, J.M., and Kidd, V. (2000). Caspase-8 activation and bid cleavage contributes to MCF7 cellular execution in a casapse-3-dependent manner dur-ing staurosporine-mediated apoptosis. J Biol Chem. 275, 9303 - 9307.
Wim Van Molle, Ben Wielockx, Tina Mahieu, Masuhiro Takada, Takahide Taniguchi, Kenji Sekikawa, and Claude Liber (2002). Immunity, 16, 685 - 695.
Varnes, M.E., Chiu, S.M., Xue, L.Y., and Oleinick, N.L. (1999). Photodymic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. Biochem. Biophys. Res. Column. 255, 673 - 9.
Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necro-sis factor. J Exp Med. 187, 1477 - 1485.
Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M., Thompson, C.B., and Korsmeyer, S.J. (2000). tBid, a membrane targeted cell death ligand, oligoerizes Bak to release cytochrome c. Genes Dev. 14, 2060 - 2071.
Wolf, B.B., Goldstein, J.C., Stennicke, H.R., Beere, H., Amarante-Mendes, G.P., Salvesen, G.S., and Green, D.R. (1999). Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood. 94, 1683 - 1692.
Wood, D.E., Thomas, A., Devi, L.A., Berman, Y., Beavis, R.C., Reed, J.C., and Newcomb, E.W. (1998). Box cleavage is mediated by calpain during drug-induced apoptosis. Oncogene. 17, 1096 - 1078.
Zamzami, N., El Hamel, C., Maisse, C., Brenner, C., Munoz-Pinedo, C., Belzacq, A.S., Costantini, P., Vieira, H., Loeffler, M., Molle, G., and Kroemer, G. (2000). Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene. 19, 6342 - 635.
Zamzami, N., Susin, S.A., Marchetti, P., Hirsch, T., Gemez-Monterrey, I., Castedo, M., and Kroemer, G. (1996). Mitochondrial control of nuclear apoptosis. J Exp Med. 183, 1533 - 44.
Zeytun, A., Hassuneh, M., Nagarkatti, M., and Nagarkatti, P. (1997). Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street. Blood 90, 1952 - 1959.
Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D.A., O’Connor, P.M., and Fornace, A.J. Jr. (1994). Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9, 3743 - 3751.
Zhang, H., Xu, Q., Krajewski, S., Krajewska, M., Xie, Z., Fuess, S., Kitada, S., Godzik, A., and Reed, J.C. (2000). BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA. 97, 2597 - 2602.
Zhang, Y., Yu, J., Unni, E., Shao, T.C., Nan, B., Snabboon, T., Kasper, S., Andriani, F., Denner, L., and Marcelli, M. (2002). Monogene and Polygene Therapy for the Treatment of Experimental Prostate Cancers by Use of Apoptotic Genes bax and bad Driven by the Prostate-Specific Promoter ARR(2)PB. Hum Gene Ther. 13, 2051 - 64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fan, X.Q., Wang, H., Qian, W., Guo, Y. (2003). Apoptosis, Cancer, and Cancer Therapy. In: Shi, Y., Cidlowski, J.A., Scott, D., Wu, JR., Shi, YB. (eds) Molecular Mechanisms of Programmed Cell Death. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5890-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5890-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3404-8
Online ISBN: 978-1-4757-5890-0
eBook Packages: Springer Book Archive